{"entity":{"type":"insider","cik":"0001418079","url":"/insider/0001418079","json_url":"/insider/0001418079.json","name":"Aberdare Ventures II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":6,"first":"2007-11-19","last":"2010-12-01","span_basis":"filed_date"},"name_variants":[{"name":"Aberdare Ventures II, L.P.","source":"filing","n_filings":6,"first_seen":"2007-11-19","last_seen":"2010-12-01"}],"transactions":[{"id":7193081,"accession":"0001104659-10-060757","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-10-060757","line_url":"/filing/0001104659-10-060757#line-6","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare Ventures II (Bermuda), L.P.; ABERDARE II ANNEX FUND L P; Aberdare GP II, L.L.C.; Aberdare Ventures II, L.P.","owner_display_name":"Aberdare Ventures II (Bermuda), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":1751936.0,"shares_owned_after_display":"1,751,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-30","filed_date":"2010-12-01","scope":"insider"},{"id":5984787,"accession":"0001209191-09-011436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-011436","line_url":"/filing/0001209191-09-011436#line-1","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare Ventures II (Bermuda), L.P.; Aberdare Ventures II, L.P.; Aberdare GP II, L.L.C.; ABERDARE II ANNEX FUND L P","owner_display_name":"Aberdare Ventures II (Bermuda), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1237113.0,"shares_display":"1,237,113","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":1422679.95,"total_display":"1,422,679.95","total_whole":"1,422,680","shares_owned_after":1720467.0,"shares_owned_after_display":"1,720,467","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-24","filed_date":"2009-02-25","scope":"insider"},{"id":3940540,"accession":"0001209191-08-034777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-034777","line_url":"/filing/0001209191-08-034777","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare GP II, L.L.C.; Aberdare Ventures II, L.P.; ABERDARE II ANNEX FUND L P","owner_display_name":"Aberdare GP II, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80000.0,"shares_display":"80,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":360000.0,"total_display":"360,000.00","total_whole":"360,000","shares_owned_after":1431388.0,"shares_owned_after_display":"1,431,388","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider","n_lines":2},{"id":3940538,"accession":"0001209191-08-034777","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-034777","line_url":"/filing/0001209191-08-034777","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare GP II, L.L.C.; Aberdare Ventures II, L.P.; ABERDARE II ANNEX FUND L P","owner_display_name":"Aberdare GP II, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12200.0,"shares_display":"12,200","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":54900.0,"total_display":"54,900.00","total_whole":"54,900","shares_owned_after":1391388.0,"shares_owned_after_display":"1,391,388","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-29","filed_date":"2008-06-03","scope":"insider","n_lines":2},{"id":3940437,"accession":"0001209191-08-033573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-033573","line_url":"/filing/0001209191-08-033573","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare GP II, L.L.C.; ABERDARE II ANNEX FUND L P; Aberdare Ventures II, L.P.","owner_display_name":"Aberdare GP II, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":1385288.0,"shares_owned_after_display":"1,385,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-23","filed_date":"2008-05-28","scope":"insider","n_lines":2},{"id":4028234,"accession":"0001209191-08-032230","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-032230","line_url":"/filing/0001209191-08-032230","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare GP II, L.L.C.; ABERDARE II ANNEX FUND L P; Aberdare Ventures II, L.P.","owner_display_name":"Aberdare GP II, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":142500.0,"total_display":"142,500.00","total_whole":"142,500","shares_owned_after":1360288.0,"shares_owned_after_display":"1,360,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-20","filed_date":"2008-05-21","scope":"insider","n_lines":2},{"id":4028227,"accession":"0001209191-08-032230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-032230","line_url":"/filing/0001209191-08-032230","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"Aberdare GP II, L.L.C.; ABERDARE II ANNEX FUND L P; Aberdare Ventures II, L.P.","owner_display_name":"Aberdare GP II, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":334600.0,"total_display":"334,600.00","total_whole":"334,600","shares_owned_after":1345288.0,"shares_owned_after_display":"1,345,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-19","filed_date":"2008-05-21","scope":"insider","n_lines":2},{"id":7186639,"accession":"0001181431-07-070482","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-070482","line_url":"/filing/0001181431-07-070482","is_derivative":false,"issuer_cik":"0001352036","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001352036","owner_cik":null,"owner_name":"ABERDARE II ANNEX FUND L P; Aberdare Ventures II, L.P.; Aberdare Ventures II (Bermuda), L.P.; Aberdare GP II, L.L.C.","owner_display_name":"ABERDARE II ANNEX FUND L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":125000.0,"shares_owned_after_display":"125,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals Inc","url":"/issuer/0001411158","role":"Ten percent owner","n_filings":1,"first_seen":"2010-12-01","last_seen":"2010-12-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001371217","name":"EnteroMedics Inc","url":"/issuer/0001371217","role":"Ten percent owner","n_filings":5,"first_seen":"2007-11-19","last_seen":"2009-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001418079","retrieved_at":"2026-08-22T16:43:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}